New Horizons in Catalysis Europe Day One
Wednesday 2 December 2009 - Pre-Conference Day
14.00 - 17.00 Exhibition Set-up
Thursday 3 December 2009 - Conference Day One
| 08.15 | Registration | ||
| |||
| 08.55 | Opening Remarks | ||
| 09.00 | Dr Paul Alsters, DSM Pharmaceutical Products, The Netherlands Reagent and Catalyst Simplification as Scale-Up Enablers | ||
| 09.45 | Dr Hayley Jackman, Pfizer Global R&D, UK Commercially-Viable Asymmetric Hydrogenation Strategies for the Synthesis of Pharmaceutically Active β-Amino Acids | ||
| 10.30 | Coffee and Exhibition - kindly sponsored by Johnson Matthey | ||
| 11.15 | Dr Weidong Liu, Array BioPharma Inc, USA Development of Practical and Efficient Deactivating Reagents for the Ring-Closure Metathesis Reactions | ||
| 12.00 | Dr Shane W Krska, Merck & Co Inc, USA Harnessing the Power of High-Throughput Experimentation for Catalytic Reaction Development at Merck | ||
| 12.45 | Lunch and Exhibition | ||
| Afternoon Session Chair: Dr Hans Donkervoort, BASF, The Netherlands | |||
| 14.00 | Professor Helma Wennemers, University of Basel, Switzerland Peptides as Asymmetric Catalysis and Templates for Silver-Nanoparticle Formation | ||
| 14.45 | Dr Antonio Zanotti-Gerosa, Johnson Matthey, USA Preparation of Tricyclic Imidazopyridines and Tricyclic Benzoimidazoles by Homogeneous Asymmetric Ketone Hydrogenation | ||
| 15.30 | Coffee and Exhibition | ||
| 16.15 | Dr Paul Murray, AstraZeneca, UK Aspects of Regioselectivity in the Mizoroki-Heck Reaction and Base Effects on the Buchwald-Hartwig Amination | ||
| 17.00 | Dr Peter Witte, BASF, The Netherlands | ||
| 17.45 | End of Day One | ||
| 17.45 | Welcome Reception - kindly sponsored by BASF | ||
